NQMC Update Service: July 4, 2016 || Quality Measurement, Evaluation, Testing, Review, and Implementation Consortium (Q-METRIC)

NQMC Update Service: July 4, 2016

Measure Summaries

Quality Measurement, Evaluation, Testing, Review, and Implementation Consortium (Q-METRIC)

• Overuse of imaging: percentage of children, ages 1 through 17 years old, for whom CT imaging of the head is obtained for the evaluation of a first generalized afebrile, atraumatic seizure without indication for CT imaging.

• Overuse of imaging: percentage of children, ages 2 through 17 years old, with post-traumatic headache who were evaluated in the ED within 24 hours after an injury, and imaging of the head (CT or MRI) was obtained in the absence of documented neurologic signs or symptoms that suggest intracranial hemorrhage or basilar skull fracture.

• Overuse of imaging: percentage of children, ages 4 through 17 years old, for whom imaging of the head (CT or MRI) is obtained for the evaluation of primary headache without indications for neuroimaging, including neurologic deficit lasting longer than 60 minutes, signs and symptoms of increased intracranial pressure, or lumbar puncture.

• Overuse of imaging: percentage of children, ages 6 months through 4 years, diagnosed with simple febrile seizure who are evaluated with imaging of the head (CT or MRI) without indications for neuroimaging, including lumbar puncture and complex febrile seizure.

• Overuse of imaging: ratio of the number of MRI scans to the number of CT scans obtained on or within 30 days after the date of evaluation for atraumatic seizure among children, ages 1 through 17 years old, within the measurement year.

• Overuse of imaging: ratio of the number of MRI scans to the number of CT scans obtained on or within the 30 days after the date of evaluation for atraumatic headache for children, ages 4 through 17 years old, within the measurement year.

• Pediatric asthma: percentage of children, ages 1 through 17 years old, identified as having asthma, regardless of severity, who are prescribed and dispensed a new medication delivery device and have documentation of the child or caregiver receiving education in the proper use of the device.